Chemoembolization of hepatic malignancy.
Treatment of primary and secondary hepatic malignancies with transarterial chemoembolization represents an essential component of interventional oncology. This article discusses patient selection, procedure technique, results, and complications associated with transarterial chemoembolization.
Gonsalves
Carin F
CF
Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Brown
Daniel B
DB
D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D018281:Cholangiocarcinoma / Q000473:pathology / Q000628:therapy; D015179:Colorectal Neoplasms / Q000473:pathology / Q000628:therapy; D005260:Female; D005781:Gelatin Sponge, Absorbable / Q000627:therapeutic use; D006801:Humans; D007459:Iodized Oil / Q000627:therapeutic use; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D053783:Magnetic Resonance Imaging, Interventional; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D018358:Neuroendocrine Tumors / Q000473:pathology / Q000628:therapy; D018579:Patient Selection; D011142:Polyvinyl Alcohol / Q000627:therapeutic use; D015641:Radiography, Interventional
D007459:Iodized Oil; D011142:Polyvinyl Alcohol